|Articles|April 19, 2012
VIDEO: Mark Zitter, MBA, Speaks About the Importance of Oncology Pathways
In this video, Mark Zitter, MBA, CEO of the Zitter Group, speaks about how oncology pathways are affecting drug use.
Advertisement
In this video, Mark Zitter, MBA, CEO of the Zitter Group, speaks about how oncology pathways are affecting drug use.
This video was taken on Thursday, April 19, 2012, at the 24th Annual Academy of Managed Care Pharmacy Conference in San Francisco, CA.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Articles
- Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD
September 17th 2025
- Radiotherapy Raises Risk of Complications After Limb STS Surgery
September 16th 2025
- miRNA Profiling May Unlock SCLC Biomarkers
September 13th 2025
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Cumulative Atropine Not Associated With Increased Risk of Ocular Events in Children With Myopia
2
West Coast Health Alliance Releases First Vaccine Guidelines, Aiming to Replace CDC Recommendations
3
Hospitals in Underserved Communities Less Likely to Adopt Health Information Technology
4
Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD
5